Clovis Oncology drops 7% as Rubraca sales missed estimates amid continued COVID-19 headwinds
May 05 2021 - 8:28AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2023 to Apr 2024